Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Am J Surg. 2019 Jun 19;219(1):145–149. doi: 10.1016/j.amjsurg.2019.06.012

Table 3.

Multivariate analysis by NCCN testing criteria.

Criterion BRCA1/2 Testing Criteria Met: BRCA mutation (n = 12) No BRCA mutation (n = 187) Odds Ratio 95% CIa p value
1 Known family history of BRCA1/2 mutation 2 (16.7%) 2(1.1%) 14.31 1.2–166.3 0.034
2 Age ≤45 at diagnosis 9 (75%) 78 (41.7%) 11.61 1.2–108.6 0.032
3 Age ≤50 and two breast cancer primaries 0 (0%) 11 (5.9%)
4 Age ≤50 with high risk family history 8 (66.7%) 92 (49.2%) 1.12 0.22–5.7 0.89
5 Age ≤60 and TNBC 3 (25%) 28 (14.9%) 1.84 0.37–9.2 0.458
6 Any age with high risk family history 7 (58.3%) 111 (59.4%) 1.25 0.28–5.5 0.769
7 Male breast cancer 0(0%) 1 (0.5%)
a

CI - Confidence Interval.